Misset J L, Gil-Delgado M A, Delgado M, de Vassal F, Machover D, Goutner A, Mathé G
Rev Esp Oncol. 1982;29(4):785-801.
Children with acute lymphoid leukemia (ALL) were treated according to two protocols. A group of 65 patients in which prognostic factors were no taken into account were treated with a combination of vincristine, asparaginase and prednisone to induce remission, followed by neuromeningeal prophylaxis with intraraquideal methotrexate and cranial irradiation with 2400 rads, two years maintenance therapy with 6-mercaptopurine and methotrexate, and then reinforcing chemotherapy, BCG scarification and injection of irradiated leukemic cell. No relapses were observed in the first 4.5 years. After 7.5 year, general survival was of 60 per 100, with 44 per 100 disease-free. A group of ALL children having a good prognosis were treated as indicated but adding adriamycin during the induction of remission and vindesine during the maintenance period. During the first three years no relapses were seen, and the general survival was 82 per 100, including a high proportion of disease-free children.
患有急性淋巴细胞白血病(ALL)的儿童按照两种方案进行治疗。一组65名未考虑预后因素的患者,采用长春新碱、天冬酰胺酶和泼尼松联合诱导缓解,随后采用鞘内注射甲氨蝶呤进行中枢神经系统预防,并进行2400拉德的颅脑照射,接着用6-巯基嘌呤和甲氨蝶呤进行两年维持治疗,然后进行强化化疗、卡介苗划痕接种和注射经照射的白血病细胞。在最初4.5年未观察到复发。7.5年后,总生存率为每100人中有60人存活,每100人中有44人无病生存。一组预后良好的ALL儿童按上述方法治疗,但在诱导缓解期加用阿霉素,维持期加用长春地辛。在最初三年未观察到复发,总生存率为每100人中有82人存活,其中无病儿童比例较高。